Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseRoles of PTEN with DNA Repair in Parkinson's DiseaseChronic Inflammation Links Cancer and Parkinson's DiseaseGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsInhibition of microglia activation as a phenotypic assay in early drug discoveryA new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseasesAlterations in immune cells and mediators in the brain: it's not always neuroinflammation!Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityAre cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K(+) channel.Protective Microglia and Their Regulation in Parkinson's DiseaseRole of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative DiseasesGastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathwaysA synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseActivation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviorsInduction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus.Progression of temporal processing deficits in the HIV-1 transgenic ratCellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment.Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.Systemic inflammation regulates microglial responses to tissue damage in vivoLack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?Protein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's DiseaseTargeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 CellsIncreased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's diseaseToll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathyGlia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytesMembrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy.Glial-neuronal ensembles: partners in drug addiction-associated synaptic plasticity.Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9.Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells.Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.Inflammasomes in neuroinflammation and changes in brain function: a focused review.The p38alpha mitogen-activated protein kinase limits the CNS proinflammatory cytokine response to systemic lipopolysaccharide, potentially through an IL-10 dependent mechanism
P2860
Q21131066-9DE64E93-9A44-4ECD-96E6-560ED301C7F6Q26744483-798E40CE-EFBB-4E24-BF6D-9CF7F61EC779Q26745344-13CEC404-41A4-4DD8-8AC0-34C4C77A306DQ26767289-33E1255C-808D-40E5-A9A7-6B4839AB1061Q26771812-847A9A75-A241-4D02-BCFA-B91BF84E1D00Q26779933-731DD3AD-ACAA-4B84-9770-B498EC09C244Q26801035-A6D19EA1-4EEA-4639-A000-A982096119A4Q26996061-40BB8047-1BB6-4BF4-803E-1957CD6B8A3FQ27005806-52D3C954-2333-46E3-8E6C-F73DC551ABF2Q27010652-937C736B-3848-48F4-A933-A4D7AC23DB62Q27027973-C4DF6B68-D3D9-4EB8-B6DC-2B2ADE07C823Q27324133-96690186-2AE4-4CF9-8477-E0D970250A2DQ27333476-A7DD92D1-876A-483B-8EC8-115D3E61390FQ28079731-2B3ECBFE-E124-4742-9953-43DDBC4564F9Q28082714-614D8BD5-DC4B-4386-AB00-62581A246329Q28478996-6E8F88C2-0787-4786-A805-A15EB1EC0617Q28830946-3CAA6545-E8D9-47AF-B468-013CAA7D4687Q29994732-739C8CFA-688A-4219-9F5F-B8CA8452B778Q30373563-CC6D58D6-4BD3-4D26-A543-0831C28BBE00Q30374656-AFE3A159-21CE-43DC-B7A3-F09D52AF5EA7Q30439617-FFFEECF6-A471-4AD9-97A2-C54D810F3E07Q30494594-CE600A46-9567-42D5-81E8-06DD7CF63E48Q30643015-5D7CF329-F5C7-4A59-9CCB-B9AB91863FCCQ30846624-F6E17107-3D91-40EB-B280-46EC5FA90E7AQ33353554-B2E8099C-FF66-4F0E-B1CA-02BB35112175Q33743531-B58600F0-2AB5-4D27-B9FA-1AA668702EEDQ33749270-34BA23FD-AD1C-4578-8461-1009EEA4D454Q33771694-EC146759-4C99-418C-A413-5C5D6D142434Q33782695-8F051124-1BEC-4C37-8F59-49E125548D8FQ33797938-481C06E3-AA7B-48EB-8948-0EE0A11F9B45Q33811654-BDE95B61-0874-42B3-8675-DBE007BA2B84Q33868678-FD51D955-1276-4BC0-BFD9-DF51568DEC6DQ33911558-74F15391-69E4-4EB6-86CF-E8AC71E9C6E9Q33920691-E64AA1A9-7086-4ABB-BAF7-DC73F4464B22Q34116743-25AE6584-F91D-4529-B7F3-8B71541111F5Q34147534-13BE9F3C-BCB8-4DA0-AE30-29F34E9DDDB7Q34171717-35E8B41D-7EA6-43FF-B391-4304A860660CQ34260323-F6020ED1-E889-4774-8C19-7AD8ED922B37Q34299338-CE9CE048-3C98-4B60-996C-93B16E6E48ECQ34324047-957F4296-A4E2-41F0-970F-5228F98F82E5
P2860
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@ast
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@en
type
label
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@ast
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@en
prefLabel
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@ast
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@en
P2860
P1476
Neuroinflammation in Parkinson ...... s for therapeutic intervention
@en
P2093
Matthew S Goldberg
P2860
P304
P356
10.1016/J.NBD.2009.11.004
P577
2009-11-10T00:00:00Z